3D). To corroborate the suggestion the mechanism of action, we explored some hallmarks of apoptosis during a 24 h HL-60 cell exposure to the α-santonin derivatives (2, 3 and 4). For this purpose, HL-60 cells treated with the lactones 2, 3, and 4 were stained with AO/EB in order to discriminate cells undergoing necrosis or selleck kinase inhibitor apoptosis. The compounds 2, 3 and 4 were able to reduce the number of viable cells at higher concentrations [2 μM (77.3 ± 1.5%, 70.7 ± 0.1% and 70.1 ± 2.1%)] and to expand the apoptosis level (20.5 ± 1.6%, 26.6 ± 0.4% and 26.4 ± 1.5%), respectively (p < 0.05). On the other hand, compound 4 was the single concentration capable to decrease the number of viable cells at 1 μM (84.1 ± 1.5%) when compared to negative control (92.5 ± 0.5%) (p < 0.05, respectively). At lowest concentrations, compounds 2, 3 and 4 also induced apoptosis (14.0 ± 1.1% and 11.8 ± 0.6% and 13.6 ± 1.6%, respectively) ( Fig. 4, p < 0.05), though in lower levels. The positive control (Dox, 0.6 μM) reduced viable cells (60.0 ± 7.3%) and increased apoptosis (36.2 ± 4.8%).

When examined under light microscopy, control cells exhibited a typical non-adherent and round morphology, while derivatives-treated cells displayed chromatin condensation, nuclear fragmentation and shrinking in all concentrations tested (Fig. 4). Dox also induced cell reduction and nuclear disintegration. Phosphatidylserine externalization was Selleck Doxorubicin determined using Annexin V test as a marker of apoptosis. Annexin V, a 35 kDa Ca2+ phospholipid-binding protein, binds to the phosphatidylserine Adenosine on the outer layer of the plasma membrane with a high affinity due to loss of polarity whereas propridium iodide (PI) bind to cells that lost membrane integrity (Krysko et al., 2008). After 24 h exposure, compounds 2, 3 and 4 at 2 μM were able to reduce cell viability (90.2 ± 1.5%, 89.5 ± 1.6% and 86.7 ± 2.7%), to induce early (7.5 ± 0.8%, 7.6 ± 1.0% and 8.7 ± 0.7%) and late apoptosis (0.8 ± 0.1%, 0.6 ± 0.1% and 0.7 0.2%) and necrosis

(1.6 ± 0.3%, 1.4 ± 0.1% and 1.6 ± 0.4%) on leukemia cells in comparison with control (92.5 ± 0.6%, 5.9 ± 1.0%, 0.2 ± 0.1% and 0.4 ± 0.1%, respectively) (Fig. 5A, p < 0.05). Meanwhile, Dox-treated tumor cells also revelaed cell viability decreasing (50.5 ± 0.2%), high levels of early apoptosis (47.5 ± 0.3%) and necrosis (1.6 ± 0.1%) following 24 h of treatment (p < 0.05). The main characteristic of cell undergoing apoptosis is the activation of caspases. The caspases can be categorized into initiator (8, 9 and 10) and executing caspases (3, 6 and 7) (Hanahan and Weinberg, 2011). At highest concentration, the compounds 2, 3 and 4 reduced cell viability (83.2 ± 5.2%, 83.4 ± 6.6% and 76.3 ± 8.5%) and increased the number of early (7.3 ± 2%, 5.8 ± 2.5% and 9.1 ± 4.1%) and late apoptosis cells (4.5 ± 0.8%, 5.